TherapeuticsMD, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Thompson Tommy G | — | Purchase | 8,400 | $1.67 | $14,028 | 23,179 | Dec 23, 2025 |
| Thompson Tommy G | — | Purchase | 325 | $1.00 | $325 | 14,779 | Apr 14, 2025 |
| Walker Marlan D | Chief Executive Officer | Purchase | 490 | $1.00 | $490 | 73,639 | Apr 14, 2025 |
| Walker Marlan D | Chief Executive Officer | Purchase | 1,136 | $0.87 | $988 | 71,982 | Apr 10, 2025 |
| Collins Cooper C. | — | Option Exercise | 8,500 | — | — | 60,516 | Feb 18, 2025 |
| Naughton Gail K | — | Option Exercise | 8,500 | — | — | 8,500 | Feb 18, 2025 |
| Thompson Tommy G | — | Option Exercise | 8,500 | — | — | 14,454 | Feb 18, 2025 |
| Walker Marlan D | Chief Executive Officer | Option Exercise | 3,467 | — | — | 66,032 | Feb 18, 2025 |
| Collins Cooper C. | — | Purchase | 4,094 | $1.73 | $7,083 | 52,016 | Aug 22, 2024 |
| Collins Cooper C. | — | Purchase | 1,200 | $1.70 | $2,040 | 47,922 | Aug 21, 2024 |
| Walker Marlan D | Chief Executive Officer | Option Exercise | 70,000 | — | — | 81,615 | Dec 7, 2023 |
| Rosen David Efraim | — | Award / Grant | 877,192 | $2.28 | $1,999,998 | 2,946,908 | Nov 15, 2023 |
| ZIEGLER JOSEPH | Principal Financial Officer | Award / Grant | 7,500 | — | — | 7,500 | Aug 17, 2023 |
| Rosen David Efraim | — | Award / Grant | 312,525 | $3.68 | $1,150,092 | 2,069,716 | Jun 28, 2023 |
| Walker Marlan D | Chief Executive Officer | Sale | 692 | $3.64 | $2,519 | 11,615 | Apr 26, 2023 |
| Walker Marlan D | Chief Executive Officer | Option Exercise | 3,030 | — | — | 8,999 | Apr 12, 2023 |
| Donegan Michael C | Prin. Fin. and Acctg. Officer | Option Exercise | 50,000 | — | — | 61,853 | Apr 12, 2023 |
| Donegan Michael C | Prin. Fin. and Acctg. Officer | Sale | 49 | $5.09 | $249 | 11,853 | Jan 26, 2023 |
| Donegan Michael C | Prin. Fin. and Acctg. Officer | Option Exercise | 519 | — | — | 6,519 | Jan 23, 2023 |
| Rubric Capital Management LP | — | Disposition | 29,000 | $1,333.00 | $38,657,000 | — | Dec 30, 2022 |
| Rubric Capital Management LP | — | Sale | 29,000 | $1,333.00 | $38,657,000 | — | Dec 30, 2022 |
| Rubric Capital Management LP | — | Purchase | 14,825 | $6.09 | $90,284 | 1,757,191 | Dec 9, 2022 |
| Walker Marlan D | Chief Executive Officer | Gift | 716 | — | — | 5,969 | Dec 8, 2022 |
| Rosen David Efraim | — | Purchase | 300 | $5.83 | $1,749 | 1,742,366 | Dec 7, 2022 |
| Naughton Gail K | — | Sale | 3,922 | $5.26 | $20,630 | — | Dec 7, 2022 |
| Bernick Brian | Co-Chief Executive Officer | Sale | 935 | $4.92 | $4,600 | 4,192 | Dec 6, 2022 |
| Walker Marlan D | General Counsel | Option Exercise | 1,010 | — | — | 6,189 | Dec 6, 2022 |
| Glickman Mark A | Co-Chief Executive Officer | Option Exercise | 1,734 | — | — | 1,734 | Dec 6, 2022 |
| Donegan Michael C | Interim CFO/CAO/VP of Finance | Option Exercise | 2,300 | — | — | 4,288 | Dec 6, 2022 |
| Rubric Capital Management LP | — | Purchase | 7,000 | $1,000.00 | $7,000,000 | 29,000 | Oct 28, 2022 |
| Rubric Capital Management LP | — | Purchase | 7,000 | $1,000.00 | $7,000,000 | 22,000 | Sep 30, 2022 |
| Collins Cooper C. | — | Option Exercise | 1,984 | — | — | 46,722 | Aug 18, 2022 |
| Naughton Gail K | — | Option Exercise | 1,984 | — | — | 3,922 | Aug 18, 2022 |
| MUSING JULES A. | — | Option Exercise | 1,984 | — | — | 4,022 | Aug 18, 2022 |
| Russell Angus C. | — | Option Exercise | 1,984 | — | — | 5,792 | Aug 18, 2022 |
| Ling Karen | — | Option Exercise | 1,984 | — | — | 4,591 | Aug 18, 2022 |
| Thompson Tommy G | — | Option Exercise | 2,976 | — | — | 5,954 | Aug 18, 2022 |
| BISARO PAUL | — | Option Exercise | 1,984 | — | — | 5,922 | Aug 18, 2022 |
| Rosen David Efraim | — | Purchase | 565,000 | $4.72 | $2,666,800 | 1,721,953 | Jul 29, 2022 |
| Rosen David Efraim | — | Purchase | 17,688 | $6.03 | $106,659 | 1,156,953 | Jul 15, 2022 |
| Walker Marlan D | General Counsel | Option Exercise | 230,000 | — | — | 258,908 | Mar 14, 2022 |
| Donegan Michael C | CAO and VP of Finance | Option Exercise | 115,000 | — | — | 129,158 | Nov 30, 2021 |
| Collins Cooper C. | — | Purchase | 1,000,000 | $0.58 | $580,000 | 2,236,864 | Nov 18, 2021 |
| Ling Karen | — | Purchase | 33,445 | $0.75 | $25,084 | 130,309 | Aug 17, 2021 |
| Collins Cooper C. | — | Purchase | 900,000 | $0.72 | $648,000 | 1,236,864 | Aug 17, 2021 |
| BISARO PAUL | — | Purchase | 50,000 | $0.79 | $39,500 | 196,864 | Aug 16, 2021 |
| Thompson Tommy G | — | Purchase | 11,000 | $0.87 | $9,570 | 715,600 | Aug 13, 2021 |
| DArecca James | Chief Financial Officer | Option Exercise | 217,167 | — | — | 217,167 | Aug 12, 2021 |
| Naughton Gail K | — | Option Exercise | 96,864 | — | — | 96,864 | Aug 10, 2021 |
| Russell Angus C. | — | Option Exercise | 96,864 | — | — | 190,364 | Aug 10, 2021 |